Skip to main content

Peer Review reports

From: Comparing the efficacy and side-effects of PDLASTA® (Pegfilgrastim) with PDGRASTIM® (Filgrastim) in breast cancer patients: a non-inferiority randomized clinical trial

Original Submission
22 Sep 2020 Submitted Original manuscript
28 Feb 2021 Reviewed Reviewer Report
3 Mar 2021 Reviewed Reviewer Report
4 Apr 2021 Author responded Author comments - Safa Najafi
Resubmission - Version 2
4 Apr 2021 Submitted Manuscript version 2
12 Apr 2021 Author responded Author comments - Safa Najafi
Resubmission - Version 3
12 Apr 2021 Submitted Manuscript version 3
Publishing
15 Apr 2021 Editorially accepted
23 Apr 2021 Article published 10.1186/s12885-021-08197-6

You can find further information about peer review here.

Back to article page